Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017.

Asian Biomed (Res Rev News) 2017 Apr;11(2):145-159

Department of Health, Thailand Ministry of Public Health, Nonthaburi 11000, Thailand.

Background: Thailand has made progress in reducing perinatal HIV transmission rates to levels that meet the World Health Organization targets for so-called "elimination" (<2%) of mother-to-child transmission (MTCT).

Objectives: To highlight the Thailand National Guidelines on HIV/AIDS Treatment Prevention Working Group issued a new version of its National Prevention of MTCT guidelines in March 2017 aimed to reduce MTCT rate to <1% by 2020.

Discussion Of Guidelines: The guidelines include recommending initiation of antepartum antiretroviral therapy (ART) containing tenofovir disoproxil fumarate (TDF) plus lamivudine (3TC)/emtricitabine (FTC) plus efavirenz regardless of CD4 cell count as soon as HIV is diagnosed for ART naïve HIV-infected pregnant women. An alternative regimen is TDF or zidovudine (AZT) plus 3TC/FTC plus lopinavir/ritonavir (LPV/r) for HIV-infected pregnant women suspected resistant to non-nucleoside reverse transcriptase inhibitors. Treatment should be started immediately irrespective of gestational age and continued after delivery for life. Raltegravir is recommended in addition to the ART regimen for HIV-infected pregnant women who present late (gestational age (GA) ≥32 weeks) or those who have a viral load (VL) >1000 copies/mL at GA ≥32 weeks. HIV-infected pregnant women who conceive while receiving ART should continue their treatment regimen during pregnancy. HIV-infected pregnant women who present in labor and are not receiving ART should receive single-dose nevirapine immediately along with oral AZT, and continue ART for life. Infants born to HIV-infected mothers are categorized as high or standard risk for MTCT. High MTCT risk is defined as an infant whose mother has a viral load (VL) > 50 copies/mL at GA > 36 weeks or has received ART <12 weeks before delivery, or has poor ART adherence. These infants should be started on AZT plus 3TC plus NVP for 6 weeks after delivery. Infants with standard MTCT risk should receive AZT for 4 weeks. Formula feeding exclusively is recommended for all HIV-exposed infants.

Download full-text PDF

Source
http://dx.doi.org/10.5372/1905-7415.1102.547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978732PMC
April 2017
13 Reads

Publication Analysis

Top Keywords

transmission rates
4
rates levels
4
levels meet
4
hiv transmission
4
perinatal hiv
4
background thailand
4
thailand progress
4
progress reducing
4
meet health
4
health organization
4
copies/ml weeks
4
weeks received
4
received art
4
"elimination" copies/ml
4
so-called "elimination"
4
organization targets
4
targets so-called
4
2017 background
4
reducing perinatal
4
national guidelines
4

Similar Publications